Wednesday, July 29 at 10:00am to 11:00am
Companies are scrambling to collaborate on the rapid development and deployment of products and services to address the pandemic. This requires highly efficient dealmaking that enables important projects to quickly proceed, but also must account for unusual challenges in:
This all must be balanced with the range of issues important in any biotech collaboration, such as the management of intellectual property and access to sufficient financial resources. This session will provide guidance and tips to consider in navigating this challenging time, which nonetheless presents tremendous opportunity for innovation.
Seth Levy, Partner at Nixon Peabody LLP, will conduct this Zoom webinar.